BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1175 related articles for article (PubMed ID: 19801494)

  • 21. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
    Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
    Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new model of congestive heart failure in rats.
    Chen J; Chemaly ER; Liang LF; LaRocca TJ; Yaniz-Galende E; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H994-1003. PubMed ID: 21685270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy.
    Flesch M; Schiffer F; Zolk O; Pinto Y; Rosenkranz S; Hirth-Dietrich C; Arnold G; Paul M; Böhm M
    Hypertension; 1997 Sep; 30(3 Pt 1):383-91. PubMed ID: 9314421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload.
    Gelpi RJ; Gao S; Zhai P; Yan L; Hong C; Danridge LM; Ge H; Maejima Y; Donato M; Yokota M; Molkentin JD; Vatner DE; Vatner SF; Sadoshima J
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1814-9. PubMed ID: 19717730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
    Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes.
    Hammoudi N; Jeong D; Singh R; Farhat A; Komajda M; Mayoux E; Hajjar R; Lebeche D
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):233-246. PubMed ID: 28643218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular pressure-volume measurements and myocardial gene expression profile in type 2 diabetic Goto-Kakizaki rats.
    Korkmaz-Icöz S; Lehner A; Li S; Vater A; Radovits T; Brune M; Ruppert M; Sun X; Brlecic P; Zorn M; Karck M; Szabó G
    Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H958-H971. PubMed ID: 27521423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Old spontaneously hypertensive rats gather together typical features of human chronic left-ventricular dysfunction with preserved ejection fraction.
    Marzak H; Ayme-Dietrich E; Lawson R; Mokni W; Combe R; Becker J; Fertak LE; Champy MF; Monassier L
    J Hypertens; 2014 Jun; 32(6):1307-16. PubMed ID: 24786294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart.
    Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc-induced cardiomyocyte relaxation in a rat model of hyperglycemia is independent of myosin isoform.
    Yi T; Cheema Y; Tremble SM; Bell SP; Chen Z; Subramanian M; LeWinter MM; VanBuren P; Palmer BM
    Cardiovasc Diabetol; 2012 Nov; 11():135. PubMed ID: 23116444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
    Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.
    Sharma V; Dhillon P; Wambolt R; Parsons H; Brownsey R; Allard MF; McNeill JH
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1609-20. PubMed ID: 18203848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.
    Park M; Nishimura T; Baeza-Garza CD; Caldwell ST; Pun PBL; Prag HA; Young T; Sauchanka O; Logan A; Forkink M; Gruszczyk AV; Prime TA; Arndt S; Naudi A; Pamplona R; Coughlan MT; Tate M; Ritchie RH; Caicci F; Kaludercic N; Di Lisa F; Smith RAJ; Hartley RC; Murphy MP; Krieg T
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):823-834. PubMed ID: 32979176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional resilience of C57BL/6J mouse heart to dietary fat overload.
    Tadinada SM; Weatherford ET; Collins GV; Bhardwaj G; Cochran J; Kutschke W; Zimmerman K; Bosko A; O'Neill BT; Weiss RM; Abel ED
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H850-H864. PubMed ID: 34477461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.